Fatty acid derivative anticonvulsants

LOGO 2120 Pill - white capsule-shape

Pill with imprint LOGO 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by United Research Laboratories/Mutual Pharmaceutical Company.

Valproic acid is used in the treatment of Bipolar Disorder; Epilepsy; Migraine Prevention; Seizure Prevention; Seizures and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Valproic acid (Valproic acid (oral/injection) [ val-pro-ik-a-sid ])-LOGO 2120-250 mg-White-Capsule-shape

Valproic acid
Generic Name: valproic acid (oral/injection) [ val-pro-ik-a-sid ]
Imprint: LOGO 2120
Strength: 250 mg
Color: White
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00677-1079 (Discontinued)
Inactive Ingredients:
Latest News
Related Drugs